Norwegian version of this page

Oslo Delirium Research Group

The group focuses upon different aspects of delirium in the elderly: Occurrence, risk factors, prognosis, prevention, treatment and pathophysiological mechanisms.

About us

Our main research focus on different aspects of delirium, or acute confusional state, in elderly people.

The group has studied delirium epidemiology and prognosis, carried out pharmacological and non-pharmacological intervention studies, and carried out studies in delirium pathophysiology.

The group members have comprehensive experience in sampling CSF and clinical data from patient cohorts.

We have established logistics for:

  • identifying hip fracture patients in the Emergency Department
  • providing consent from either the patient or a close relative
  • gathering proxy information on pre-fracture cognitive status by validated instruments
  • obtaining CSF and blood at the onset of spinal anaesthesia
  • monitoring the patients with validated tests during the perioperative phase regarding delirious symptoms, and
  • testing the patients cognitively at follow-up

Long-term goals

Through innovative research design, good utilization of the department's own patient materials, national and international networks and so on, we aim to develop into a leading European center for research on delirium.

In the years ahead, we will especially prioritize treatment research, epidemiology and research on pathophysiological mechanisms.

Our biobank spinal fluid samples from hip fracture patients who are well clinically mapped with respect to delirium represents a unique collection of biological materials, and we will therefore prioritize research on this to elucidate pathophysiological hypotheses in collaboration with basic scientists.

We have an ongoing recruitment of patients at several sites in Norway, and are continuously expanding our biobank.

Our group hosted the 12th annual meeting in the European Delirium Association at Hotel Bristol, Oslo November 16th – 17th 2017.

On-going projects

  • Alpha 2 adrenergic receptor agonists for the prevention of delirium and cognitive decline after open heart surgery (ALPHA2PREVENT): randomised controlled trial
  • Cooperation for improved pharmacotherapy in frail elderly people – The COOP study. A randomized controlled trial
  • Adverse outcomes after delirium. A longitudinal study of patients with hip fracture with and without delirium
  • Home-based patients with delirium
  • Haemodynamic regulation in elderly persons
  • Pathophysiology of delirium
  • Spinal fluid findings from healthy elderly
  • Acute sick elderlies in medical departments
  • Delirium in care transitions

Cooperation

International Collaboration

  • Edinburgh Delirium Research Group, Department of Geriatric Medicine University of Edinburgh, UK. CSF biomarkers in delirium (inflammation, neurotransmitters, cortisol), delirium severity (survey), CSF biomarker review.
  • Colm Cunningham: CSF biomarkers in delirium (inflammation). Trinity College, Dublin, Ireland.
  • Henrik Zetterberg, Kaj Blennow: CSF biomarkers (inflammation, neuropathology). Department of Psychiatry and Neurochemistry, Clinical Neurochemistry Lab, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden
  • Chris Fox: CSF biomarkers in delirium and dementia. Norwich Medical School, University of East Anglia, UK.
  • Gideon Caplan: CSF biomarkers (inflammation, metabolism) in delirium and dementia. University of New South Wales, Sydney, Australia.

National collaboration

  • Centre for Dementia and Delirium Research. Cooperation between our group, Institute of Basic Medical Sciences (UiO) and Norwegian Defence Research Establishment (FFI). 
  • Frede Frihagen, Johan Ræder: Collection of CSF from hip fracture patients. Dep of Orthopedic surgery/Dep of Anesthesiology at Oslo University Hospital, Norway
  • Wender Figved, Marius Myrstad, Ullrich Sprang: Collection of CSF from hip fracture patients. Dep of Orthopedic surgery/Dep of Anesthesiolgy at Vestre Viken, Bærum, Norway.
  • Asbjørn Årøen, Christian Pollmann: Collection of CSF from hip fracture patients. Dep of Orthopedic surgery/Dep of Anesthesiology, (Adam Essack) at AHUS.
  • Anders Fjell, Kristine Walhovd: CSF and imaging (MR/fMR) changes in normal aging. Research Group for Lifespan Changes in Brain and Cognition, Department of Psychology, University of Oslo, Oslo, Norway
  • Ingebjørg Seljeflot, Ragnhild Helseth, Vibeke Braseth: CSF biomarkers in delirium and dementia. Center for Clinical Heart Research, Oslo University Hospital
  • Lasse Giil: CSF biomarkers in delirium and dementia (inflammation, metabolism, neurodegeneration). University of Bergen
  • Anne Brita Knapskog: CSF biomarkers and imaging changes (MR) in dementia and normal aging. Dementia Research Group, Oslo University Hospital.
  • Mari Schibstad, Roy Olsen: Collection of CSF from hip fracture patients. Dep of Geriatrics/Dep of Anesthesiology, Arendal Hospital.
  • Dag Aarsland, Mathias Hella, Hogne Sønnesyn. Linking delirium and Lewy Body Dementia. CSF biomarkers. Epidemiology. CSF collection from hip fracture patients. Stavanger University Hospital.
  • Evandro Fang. CSF biomarkers (protoemics, mitophagy) in delirium and dementia. Akershus University Hospital.
  • Tormod Omland, Helge Røsjø. CSF biomarkers (inflammation) in delirium and dementia. Akershus University Hospital.
     
Published Apr. 14, 2015 11:02 AM - Last modified Apr. 19, 2024 11:37 AM

Contact

Group leader

Participants

  • Leiv Otto Watne Universitetet i Oslo
  • Torgeir Bruun Wyller Universitetet i Oslo
  • Kristi Henjum Universitetet i Oslo
  • Silje-Emilie Rygg Universitetet i Oslo
  • Eli Rudi Universitetet i Oslo
  • Bjørn Erik Neerland
  • Karen Roksund Hov
  • Ane-Victoria Idland
  • Maria Krogseth
  • Marte Sofie Wang-Hansen
  • Gunilla Martinsson
  • Nathalie Bodd Halaas
  • Shams Dakhil
  • Jelena Gulubovic
  • Morten Kvam Olafsen
  • Wilhelm Frich
Detailed list of participants